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Lymphocyte function associated antigen 1 (LFA-l) and its 
ligand intercellular adhesion molecule 1 (ICAM-l) are cell 
surface adhesion molecules important in many }ymphocyre-
mediated responses. Recem in vitro studies have demon-
mated that the cytokine interferon-gamma (fFN-y) can in-
duce ICAM-l expression by keratinocytes. and that 
lymphocytes adhere to IFN-y treated kera[ino~tes. In view 
of the importance of keratinocytc/ lymphocyte interactions 
in the pathogenesis of cutaneous disease, we have examined 
the effects of in vivo IFN-yon cutaneous expression ofLFA- l 
and ICAM-l . Fourteen volunteers received intradennal 
IFN-y (dose: l or 10 Jig) daily for 3 d. Biopsy was obtained on 
day 6. Cryostat sections were stained by the peroxidase anti -
peroxidase technique employing murine monoclonal anti -
T he leukocyte lmegrins comprise a family of three het-erodimer glycoproteins termed Iympbocyte: function associated amigen-l (LFA-l), Mac 1, and p 150,95. Each is composed of a common chain (CD18) and a distinct chain (CDt h , eD 1tb, and CDllc. respec-
tively) [I]. LFA- l , Mac 1, and p 150,95 arc cell surface glycopro-
teios involved in inrercelJu,/ar adhesion reactions [2] unJike rhe 
other nu'mbers of the imegrin family , which act as receptors for 
extracellular matrix components such as 6bronectin [3]. While ex-
pression of Mac 1 and p 150,95 is limited to cells of the monocyte/ 
macrophage lineage and ncutrophils, LFA-1 is expressed by all leu-
koc),res, including T and B lymphoCYt<s and nul) cells [4J. 
Antigen-independent adhesion via LFA-l appears to be essential in 
the dcvelopment of most lymphocyte mediated responses~ includ-
ing helper T lymphocyte responses, cytotoxic T cell responses, and 
adhesion oflymphocytes to endothelial cells and fibroblasts [5] . 
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Abbreviations: 
APAAP: alkaline phosphatase anti alkaline phosphataSe 
ICAM-t : intercellular adhesion molecui<--l 
IFN-y: interferon-gamma 
LFA-I : lymphocyte function associated antigen-l 
p.g: microgram 
PAP: peroxidase anti-peroxidase 
bodies to CO ll, C018, and ICAM-l. IFN-y intensified 
I CAM-l expression by dermal endothelial cells and induced 
keratinocyte expression of ICAM-I. Furthermore, after ad-
ministration of 10 Jig of IFN-y LFA-l positive (LFA + vel 
lymphocytes were observed along the basement membrane 
zone closely related to ICAM-l + ve basal keratinocytes and 
also surrounding dermal endothelium. Exposw:e to rFN-y 
induced expression of both COlla and CO l8 antigens on 
epidermal Langerhans cells. T hese studies suggest that the 
distribution of adherence molecules expression within cuta-
neous tissue in vivo is modulated by IFN-y. and that these 
alterations may be important in interactions involving cuta-
neous immunocompetent cells. ] Invest Dermatol 93:439-
442, 1989 
More recently, the ligand for LFA-l. termed intercellular adhe-
sion molccule- t (ICAM- J), has been identified l6,71. lr is a single: 
chain glycoprOtein of molecular weight 90 kd showing significant 
sequence homology with molecules belonging to the so-called im-
munoglobulin supergene famil y [8]. It has a similar tissue distribu-
tion to HLA-DR, being expressed on the surface of endothelial 
cells. fibroblasrs, dendritic cdJs, and certain ephhelioJ cdls; fOI ex-
ample, thymic epithelium (9J. In addition , cytokines such as imer-
feron-gamma (IFN-}'), imerleukin-l [9]. and tumour necrosis factor 
[10) regulate ICAM-l expression by certain cell types, including 
vascular endothelial cells. This suggests that cytokine controlled 
ICAM-l / LFA-l interactions may be involved in. the sequestration 
of lymphocytes (LFA-l + ve) into sites of local inflammation, be-
cause adhesion of lymphocytes to endothelial cells appears to be an 
importalH step in this process. 
In normal human epidermis kCrl.tinocytes do nor express 
lCAM-l [9]. However, in vitro srudies have demonstrated that re-
combinant IFN-y treated human keratinocytes express ICAM-l 
[1 1]. and that lymphocytes adhere to kerarinocytes incubated with 
IFN-y [12] , a reaction thar cm be blocked by monoclonal antibodies 
to either l CAM-1 or LFA-l. Furthermore, adherence via teAM-1/ 
LFA-1 is the only known adhesion pathway between keratinocytes 
and lymphocytes [\1 J. 
Whether the in vitro effects of IFN-y on human keracinocytes 
occur in vivo is not known. In view of the potentially important role 
of kerarinocyre-Iympbocyte interactions in [he pathogenesis of in-
fl ammatory cutaneous disease [13], we have assessed rbe effects of 
intradermally administered recombinanr humlln fFN-y on the dis-
tribution of these adherence molecules in normal human skin, in 
vivo. 
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MATERIALS AND METH ODS 
Subjects Fourteen 2dult male volunteers (age range 18 - 44) wtrt 
recruited for the srudy. All received a general medical examination, 
incl uding blood pressurr- and remper2ture measurement, and were 
screened for haematologic and biochemical abnonnali.ries. 
Interferon-Gamma Recombinant hum2n interferon-gamma 
(sp<'cifi c activity = 2 X 107 U per mg) was kindl y donated by Bio-
gen incorporated. Each volunteer received an intradermal injection 
of recombinant IFN-ydilmcd in 0. 1 ml ste.rilC' water. ro onc precise 
area on the lefr huttock d.aily for three consecu tive days. Nine vol-
unteers received a dail y dose o f 10 jJg IFN-y, and four received l,ug 
dail y. A similar area on the right butlock received 0.1 ml of d il uent 
only for three consecutive days, as control. 
Biopsy Biopsy was obtained 5 dafter rhe initial injection (i.e .. 
s~udy day 6) from injected sites on both buttocks by 6 mm punch 
bIOpsy under local anaesthetic. Each specimrn was bisected with 
half snap frozen prior [ 0 storage in liquid nitrogen .and rhe second 
half fixed and processed for staining with haem.atoxylin and eosin. 
5-)Jm cryosta t sections were then cur from each frozen biopsy. air 
dried. and fixed in accrone for to min prior to immunohistochemi· 
cal analysis. 
lmmuoohistoche,mistry The three.srcp peroxidase allfi.peroxi-
dase (PAP) immunohistochemic.al assay was used, as described 
dS{'where {14]. employing diaminobenzidine as subst rate. This 
provides more scnsitiv(" results than standard inducer immunoper-
oxidase reactions. without loss of spccificiry . The primary murine 
monoclonal antibodies used are listed in T .able 1. Positiv(' staining 
was identified as .a brown reaction product under the light micro-
scope. 
T a determine the phenotype of epidermal cells expressing LFA· I 
(see larer), a double immunoel1zymatic technique as described by 
Allen er ,I [15] was employed. using rhe , nribodies OKT 6 (CDI) 
and MH M24 (CD1 8). OKT6 was linked ro an allealine phosph,rase 
ami-alkalinc phosphatase catalysed reaction (APAAP), and 
MHM24 was linked to l PAP reaction. In thi s way CO l molecules 
were identified as a blue reacrion product and CO IS as a brown 
product. Double labe led cells .appeared bl.ack and could easily be 
diiferendared from singly l.abeled cells. 
RESULTS 
ICAM·1 In the control biopsy ~pecimens (no IFN-y administered) 
positive stain ing for IC AM-l was limited to dennal endothelial 
cells (Fig 1). Ie AM-I expression by Langerhans cells. keratino-
cytes, and cd ls of the acrmyringium was unifonnly .absent. One 
microgram of recombinam human IFN-y injected dail y for three 
consecurive days induced cel l surface expression ofICAM- l by basal 
kcratinocyres, while suprabasaJ keratin ocyre and Ltngerhans cell 
staining was absent (Fig 2). Within the dennis.a sparse infi ltrare was 
observed of si mi lar degree to that observed within the control biop-
sies. T en mkrogr::lms of recombinant human IFN-yinduced intense 
Te AM- l expression on the surface of most keratinocytes; st.aining 
was maximal along the b.asal laye r (Fig 3). A few sc.arrered cells 
throughout a moderate de rmal inflammatory infiltrate also ex-
pressed ICAM- l. The i.ntensiry of sraining for JCAM-l by derm.al 
endothelial cells was observed to be gre:acr after administrariotl of 
IFN-l' (both 11'g and 10 pg) (Fig 4). 
Table I. Table of the Primary Murine Monoclonal Antibod.ies 
(McAb) Used in rhis Srudy . 
McAh Specificiry Dilution Source 
RRI / I ICAM- I 1 ,5000 T . Spring" (6) 
MHM23 CO lla 1, 160 Oako 
MHM24 CD I8 
" 160 Oako 
Leu t CD3 1,20 Becton·Dickin!oll 
OKT6 CO l 1, 20 Onho Diagnostics 
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Figure 1. Phoromicrograph or normal skin [hat received dil uent onJ y 
st~illt'd with antibody RR 1/ 1. Only dermal C'lIdofhelial cc:1l~ (arrow) cxpr~s 
ICAM-I (X 150)_ 
LFA-l In normal human skin not c'xposed [ 0 IFN-y. cellsexpress-
ing both COlla and CD l8 antigens. pr("sumably leukocytes, were 
observed scattered rh roughout the sparse dermal inliltrate. These 
were si tuated m.ainly around dennal vessels. No epidermal positiv-
ity waS noted for either antigen; in p:micular. de ndritic cell expres-
sion of CO 18 was not observed. No change was noted after admin· 
i5tration of 1 ,ug of recombin.am human IFN-}'. When 10 Jlg of 
recombinant llUman IFN-y was administered inrradcrmally:t mod-
era te dCrln.a1 innlture was produced. Of these infiltratin g cd Is, 
ne.ad y all expressed both CD11 a and CD 18 antigens . Tile majori ty 
were closely arranged around dermal vessels (ICAM-l + ve), but a 
sign i6c:mf proportion were also obsrrved along the basement mem· 
brane zone, closely applied [0 basal keratinocytes (lCAM- I + vc) 
(Fig 5). ImmunopcTOxidase labeling of serial5 ,um sections with 
Leu I an tibody, a pan T cd l marker, demonstrated [bat the majoriry 
of these cells were T lymphocytes. 
As previously mentioned. expression of LFA- I by epidermal Lan-
gerhans cdls in control biopsy specimens was nO[ observed. Ten 
micrograms of iF N·y. however. induced expression ofborh CO ll a 
and CD IS .antigens on dendritic cells throughout the epidermis, 
although C D 18 expression was more intense (Fig 3). Double label· 
Fig ure 2. Photomicrograph of nonnal sun injected with 1 JIg recombinant 
IFN-p (XJ) Stained for ICAM-I. Bas21 kcratinocYfcs c:xprC'ss rCAM.! . but 
suprab2521 nall1ing is 2hscm (X 1 SO). 
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Figure 3. Phoromicrograph of norm:'!1 skin injecu·d with JO.u~ recombi-
n:ult IFN·i' (X3) stllincd for l e AM-1, Kcrarinocyrcs display strong cell 
surface cxpre:~sion of IC AM· I. which is maximal in the basal layer (X 200). 
ing e.xperiments revealed that 60% of epidermal C Dt 8 positive 
cells co-localized with O KT6 antibody. 
H isw/ogic cxarnin.uion of fixed sections- sraincd with haem.nox-
ylin and eosin revealed no evidente of kerarinocyte damage. In 
particular , no dyskeratotic cel ls nor hydropic change WdS obse rved. 
DISCUSSION 
This stud)' has demonstrated that, in vivo, fFN- Yinduced kcracino-
cyte tCAM-1 expression, tht· intensity of wh.ich was dependent o n 
th e- concenrracion of IFN-y administered. Furthermore , LFA-1 + 
vc cells were observed along the basement membrane zone, consist-
ent with adhesion of lymphocy tes to lCAM·l + ve basal keratino-
c)'tes. I n the epidermis, Langerhans ce lls expressed both C D r ta and 
CD'I 8 an.tigcns after exposu re to IFN-y. Within th~ dermis, endo· 
thelial cell JC AM- J express-jon was intensified. and LFA + ve cells 
were observed in close proximity to these cells. 
111 vitro studies have demonstrated that lymphocytes adhere to 
keratinocytcs via LFA-l. a lymphocyte surface glycorrorein, and its 
ligand ICAM- I is expressed by keratinocytes j11 ,12. This interac-
cion, however, is dependent o n prior exposure of keracinocyccs ro 
IFN· }f, because unstimulated keratinocy tes do not possess teAM- t . 
Th e: importance o f these molecules lies in the fact that adhesion of 
lymphocytes to target ce lls via th is pathway isan obligate step in th~ 
induction and mainten;mce ofT -cell responses such as T belper cdl 
and cytotoxic T -cell activity. Alterations in keratinocyte- lympho-
cyte interactions arc thought to playa major role in the pathogenesis 
of many inflammatory cutaneous diseases l13}, such as discoid lupus 
erythematosus. lichen planus, and cutaneo us graft versus host dis-
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Figure .. . Photomicrograph of normal skin i_njecrcd with 10,ug recombi-
nan t IFN-i' (X 3) stained for ICAM·I . Intens~ exprc:ssion of IeAM· f by 
dermal endothelial cells is observed (X 250). 
casc, whe re lymphocytes are in dose apposition to kcratinocytes. 
Each of these diseases is furrher characterized by an infiltrate rich in 
activated T lymphocytes [ t 6] (the presumed source ofIFN-Y) and by 
kcrarinocyre expression of HLA-DR 1l7}, suggesting that IFN-y 
ha~ porcnt epidermal effects in vivo. Our study demonstrates that 
IFN-)I induces similar changes in vivo to [hose observed in vitro, 
suggesting that it may playa cemral rol e in regulating kcr3tino-
cyre/lymphocyte interactions in vivo. 
Although rhe immunoperoxidasc assa}' used in this srudy is not 
quantitative, il is ou r impression tha t intradermal IFN-y increased 
tilt' expression of lCAM-l on dermal endothelial cells, consistent 
with the results of in vitro studies [9]. The consequences of in-
creased expression may be to facilitate the sequestration of LFA-l 
+ ve celh into rhe dermis, t hereby helping to promote an inllamm<l-
tory in.filtra te. This is further suggested by the observed close appo-
sirion of LFA-l + ve cells to Ie AM- l + ve endothelial cells and by 
o ther group's findings that lymphocytes adlu'r~ to dermal endothe-
lia! cells. ill vitro [181, It is interesting {Q speculate what the initial 
Figure 5. Photomicrograph of normal skin injecred with 10,ug recombi-
!latH lFN~y (X 3) stain~d with anribody to CD 18. Small round infil trating 
cells (Mark arrows) arc seen along the ba~cmenr membrane zone. Sc3ttered 
dcudritic fi gures (Ivhitt armlvs) are seen throughout the epidermis (X2S0). 
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trigger for this may be, C ytok.ine productio n byanrigen.stimulated 
keratinocytes may be responsible fot the enhanced expression of 
JC AM-l by endothdium. One potentially responsible peptide is 
IL-l , a known product of keracinocytes [19J, which is capable of 
inducing reAM-l expression by endothelial cells. but not keratino-
cytes ft 1 J, in vitro. 
It is of interest tha t dendritic cells within the epidermis expressed 
both COlla and CD tS anrigens after exposure to IFN-Y. D ouble 
labeling experiments with antibodies OKT 6 and MHM24 demon-
strated that most d endr itic epidermal cells expressing C01S mole-
cules were also CD t positive. Although we did not idencify positive 
staining of Langerhans cells for either Olntigen in the comrol biop-
sies, other investigators have observed exptession o f CO tS, but not 
CO t h antigens, o n Langerharu cells, implying that they may be 
immature leukocytes (20). The inducible ch anges in Langerhans 
cell LFA- t expression suggest that IFN-y may be i_n volved in tite 
regulation of Langerha.ns cdl function. W e can not discount t be 
possibility. however. that the observed changes in Langerhans cell 
surface antigen expression are secondary effects of mediators such as 
other cytokines. released by cells within the IFN-y induced inflam· 
macory infiltrate. Nevertheless. this seems unlikely, because epider-
mal dendritic cell expression of LFA· I was observed in sites distant 
from the perivascular innlrrate . 
The al terations in distribution of adbesion mo JecuJe expression 
induced in normal skin by IFN-y strongly suggest chat it is impor-
tant in regulation of dermal endothel ium/lymphocyte. keratino-
cyte/lymphocyte, and, perhaps. keratinocyte/Langerhans cell in-
teractions. Fu rthermore, the inducible expression of IC AM-t on 
keratinocytes provides furtner evidence of an important ro le for 
keratinocytes in skin immune responses, 
TJIt! author; would lik, to thaHk Dr T .A.Springtr for Jds kind donation oj murine 
mCH(KloHa/ aHtiiwJy, RR1 / 1. 
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